Barclays’s Equillium EQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112K Buy
+35,000
New +$83.9K ﹤0.01% 3987
2024
Q4
Sell
-104
Closed -$87 5331
2024
Q3
$87 Buy
+104
New +$87 ﹤0.01% 5188
2021
Q4
Sell
-15
Closed 4264
2021
Q3
$0 Hold
15
﹤0.01% 4807
2021
Q2
$0 Buy
+15
New +$95 ﹤0.01% 4922
2020
Q4
Sell
-100
Closed -$1K 4958
2020
Q3
$1K Buy
+100
New +$810 ﹤0.01% 5141
2019
Q3
Sell
-96
Closed -$1K 6804
2019
Q2
$1K Sell
96
-1,379
-93% -$8.67K ﹤0.01% 6834
2019
Q1
$12K Buy
1,475
+1,325
+883% +$10.9K ﹤0.01% 6509
2018
Q4
$1K Buy
+150
New +$2.08K ﹤0.01% 6789

Other funds holding EQ

Barclays's EQ Position: Q2 2026 in Review

Barclays opened a new position in Equillium (EQ) in Q2 2026: 35,000 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #3987 among its holdings. This is a return to the name: Barclays previously reported a position in EQ as recently as Q3 2024.

Barclays first reported a position in EQ in Q4 2018 and has held it in 8 quarters since. 60 funds tracked by Wall St. Rank hold EQ as of Q2 2026.

  • Barclays held 35,000 shares of Equillium worth $112K as of Q2 2026.
  • Equillium was a new Barclays position in Q2 2026.
  • Equillium made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3987 holding.
  • Barclays first reported a position in Equillium in Q4 2018 and has held it in 8 quarters since.
  • 60 funds tracked by Wall St. Rank held Equillium as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.